Non-Muscle Invasive Bladder Cancer Videos

Trained Immunity as a Molecular Mechanism for BCG Immunotherapy - Sita Vermeulen

January 27, 2021

Details

Nadofaragene Firadenovec for BCG Unresponsive NMIBC - Girish Kulkarni

January 5, 2021

Details

How to Define Treatment Failure After BCG Treatment for Nonmuscle-Invasive Bladder Cancer - Peter Black

October 14, 2020

Details

High-Risk Non Muscle-Invasive BCG Unresponsive Bladder Cancer - Molecular Subtypes - Woonyoung Choi

October 14, 2020

Details

Adherence to Guidelines-Based Management of Non-Muscle Invasive Bladder Cancer Among Society of Urologic Oncology (SUO) Members - Justin T. Matulay

August 4, 2020

Details

Results of the SUO CTC Phase III Nadofaragene Firadenovec Trial for BCG Unresponsive NMIBC - Colin Dinney

July 6, 2020

Details

Phase III Nadofaragene Firadenovec for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Joshua J. Meeks

February 28, 2020

Details